SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?


To: surelock who wrote (1584)5/8/2000 12:24:00 PM
From: allen menglin chen  Read Replies (1) | Respond to of 3392
 
Herb Part 2: Why Cyber-Care's Credibility May Be on the Line
By Herb Greenberg
Senior Columnist
5/8/00 8:30 AM ET


The plot gets thicker yet. For Cyber-Care (CYBR:Nasdaq - news - boards) it was a credibility grabber: A press release touting a clinical review completed by a joint project with the University of Iowa that found that its heavily hyped Electronic Housecall patient monitoring system "reduced health care costs significantly" over traditional methods. The press release, on Feb. 24, quoted Dr. Michael Kienzle, director of Telemedicine for the University of Iowa Health Care, as saying, "We are seeing significant benefits both in terms of costs and clinical outcomes." Cyber-Care then went on to describe its Electronic Housecall System as an "Internet-based technology system that provides remote monitoring of individuals for health care purposes."

The key word here, folks, is "Internet." That "Internet" connection has been the sizzle to Cyber-Care's story -- the sizzle that caused its stock to rocket to a high of 40 in February from pennies last August. It also helped separate Cyber-Care from other companies, like Kodak (EK:NYSE - news - boards), whose monitoring systems rely on old-fashioned telephone lines.

Just one problem: Kienzle's comments on the cost effectiveness of Cyber-Care's product had nothing to do with the company's Internet product. Instead, his comments referred to a study using another Cyber-Care product that, like Kodak's, uses telephone lines -- a product for which Cyber-Care has not yet even applied for FDA approval. "We have never used their Internet-based product," Kienzle told my associate, Mark Martinez. "Our experience is with the POTS [plain old telephone service] ... I do not want to misrepresent our experience and say this is an Internet program. This is a POTS program."

POTS? Pans! Will somebody please tell me what's going on here? Turns out, as Kienzle told Mark, the press release that was issued wasn't the one Kienzle had authorized. The one he authorized included the model number of the POTS product: EHC 200; the press release that was issued didn't include any model number, leaving the impression that the good doc might have been talking about the Internet product -- the EHC 500.

Why the switcheroo? "One of the reasons that it occurred is because we did not want to confuse anyone," says Linda Roman, senior vice president at Cyber-Care. "We thought it would be confusing if we put in a model number."

Confusing, indeed. How would they have explained that he was talking about a product that hasn't yet been pitched to the FDA, that relies on old-fashioned technology and, worst of all, doesn't have Internet sex appeal?

Peppering Salton
Last week's item on Salton (SFP:NYSE - news - boards) mentioned that CEO Leonhard Dreimann picked a fight with short-sellers on his company's conference call when he said, "This month ... leads us to the 10-month anniversary since the company's shares have experienced significant short activity, and after 10 months there are only two months for shorts to qualify for capital gains losses."

He spoke for a few minutes more and then turned the mike over to President William Rue. As Rue began to speak there were a few muffled comments in the background. Turns out those muffled comments were Dreimann saying, "Like that short statement ... 10 months into the year ... garble ... about the capital gains." (There were then sounds of chuckles.) Rue, sounding somewhat red-faced, then said, "We can hear you." Ah, but the joke is on Dreimann. According to numerous short-sellers, short sales never qualify for long-term capital gains. (Badda-bing, badda-ba-ba-ba-ba-boom!)

Meanwhile, back in February -- about two weeks before Salton filed a shelf-registration statement with the Securities and Exchange Commission to sell as much as $100 million in securities -- Chairman David Sabin sold 54,000 shares at prices ranging from $50.62 to $58.60. Then, four days after the registration statement was filed, he sold another 9,000 shares at prices ranging from $50.27 to $50.90. Salton closed Friday at 42 3/8. Why did he sell ahead of his own company? A Salton spokeswoman said Sabin was traveling Friday and could not be reached. (Whenever I get that response, I always wonder, "Don't these guys ever check in with their office?!")

PS: Hold the hostile emails because I won't read them.

thestreet.com



To: surelock who wrote (1584)5/8/2000 3:34:00 PM
From: Murray_Mac  Read Replies (1) | Respond to of 3392
 
surelock, you never cease to amaze me!!

What you have just posted is NOT new to me and I completey agree and understand. But where is your point??

This whole debated started with you, stating in Post #1517 that John Hainse has been the largest seller, and here is your exerpt to refresh your memory.......

>>>From todays S3A, amended to add a further 8.2 million
available for resale.
John Haines the largest seller.....hmmmmmm <<<

Now what does your post have to do with justifing your earlier comment on John selling his shares. I am still stating that he has NOT sold one share.......has NOT even filed a Form 144 and couldn't, even if he wanted to.

Why??

Because his shares are restricted by the acquisition and locked up for a one year period.

As soon as you are done with your teachings of old news, perhaps we can get you to comment on your accusation that John is a large seller of shares.

If you can't......then don't bother posting and wasting my time.

Murray